Emerging Contaminants and the Implications for Drinking Water

International Journal of Water Resources Development

Volumn 28, Issue 2, 2012, Pages 247-263

  Fawell, John ^a   Ong, Choon Nam ^b  

^a CRANFIELD UNIVERSITY   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL METHOD; EMERGING CONTAMINANT; LOW LEVEL; MEDIA ATTENTION; PERSONAL CARE PRODUCTS; SCIENTIFIC COMMUNITY; TRACE AMOUNTS; WATER SOURCE;

TECHNOLOGY;

ANALYTICAL METHOD; CHEMICAL POLLUTANT; DRINKING WATER; POLLUTION EXPOSURE; WATER POLLUTION; WATER SUPPLY;

EID: 84860914071     PISSN: 07900627     EISSN: 13600648     Source Type: Journal    
DOI: 10.1080/07900627.2012.672394     Document Type: Article

References (52)

1. Ahrens, L., Felizeter, S. and Ebinghaus, R. 2009. Spatial distribution of polyfluoroalkyl compounds in seawater of the German Bight. Chemosphere, 76: 179-184.
2. Barber, L. B., Brown, G. K., Nettesheim, T. G., Murphy, E. W., Bartell, S. E. and Schoenfuss, H. L. 2011. Effects of biologically-active chemical mixtures on fish in a wastewater-impacted urban stream. Science of the Total Environment, 409(22): 4720-4728.
3. Benotti, M. J., Trenholm, R. A., Vanderford, B. J., Holady, J. C., Stanford, B. D. and Snyder, S. A. 2009. Pharmaceuticals and endocrine disrupting compounds in US drinking water. Environmental Science and Technology, 43: 597-603.
4. Borm, P. J., Robbins, D., Haubold, S., Kuhlbusch, T., Fissan, H., Donaldson, K., Schins, R., Stone, V., Kreyling, W., Lademann, J., Krutmann, J., Warheit, D. and Oberdorster, E. 2006. The potential risks of nanomaterials: a review carried out for ECETOC. Particle and Fibre Toxicology, 14(3): 11-19.
5. Boxall, A. B., Kolpin, D. W., Halling-Sørensen, B. and Tolls, J. 2003. Are veterinary medicines causing environmental risks?. Environmental Science and Technology, 37(15): 286A-294A.
6. Bull, R. J., Crook, J., Whittaker, M. and Cotruvo, J. A. 2011. Therapeutic dose as the point of departure in assessing potential health hazards from drugs in drinking water and recycled municipal wastewater. Regulatory Toxicology and Pharmacology, 60: 1-19.
7. Clark, J. H., Breeden, S. W. and Summerton, L. 2010. "Green(er) pharmacy". In Green and Sustainable Pharmacy, Edited by: Klaus, K. and Hempel, M. 37-60. Berlin: Springer.
8. Cooney, C. M. 2009. Study detects trace levels of pharmaceuticals in US drinking water. Environmental Science and Technology, 43(3): 551-551.
9. Daughton, C. G. 2001. "Pharmaceuticals and personal care products in the environment: overarching issues and overview". In Pharmaceuticals and Care Products in the Environment, Edited by: Daughton, C. G. and Jones-Lepp, T. L. 2-38. Washington, DC: American Chemical Society.
10. Daughton, C. G. and Ruhoy, I. S. 2009. Environmental footprint of pharmaceuticals: the significance of factors beyond direct excretion to sewers. Environmental Toxicology and Chemistry, 28(12): 2495-2521.
11. Daughton, C. G. and Ternes, T. A. 1999. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environmental Health Perspectives, 107: 907-937.
12. Ericson, I., Domingo, J. L., Nadal, M., Bigas, E., Llebaria, X., van Bavel, B. and Lindström, G. 2009. Levels of perfluorinated chemicals in municipal drinking water from Catalonia, Spain: public health implications. Archives of Environmental Contamination and Toxicology, 57(4): 631-638.
13. Fawell, J. K. and Chipman, K. 2000. Endocrine disrupters, drinking water and public reassurance. Water and Environmental Management, 5(6): 4-5.
14. Fawell, J. K., Sheahan, D., James, H. A., Hurst, M. and Scott, S. 2001. Oestrogens and oestrogenic activity in raw and treated water in Severn Trent Water. Water Research, 35(5): 1240-1244.
15. Fick, J., Lindberg, R. H., Parkkonen, J., Arvidsson, B., Tysklind, M. and Larsson, D. G. 2010. Therapeutic levels of levonorgestrel detected in blood plasma of fish: results from screening rainbow trout exposed to treated sewage effluents. Environmental Science and Technology, 44(7): 2661-2666.
16. Focazio, M. J., Kolpin, D. W., Barnes, K. K., Furlong, E. T., Meyer, M. T., Zaugg, S. D., Barber, L. B. and Thurman, M. E. 2008. A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States. II: Untreated drinking water sources. Science of the Total Environment, 402: 201-216.
17. Fromme, H., Tittlemier, S. A., Völkel, W., Wilhelm, M. and Twardella, D. 2009. Perfluorinated compounds: exposure assessment for the general population in Western countries. International Journal of Hygiene and Environmental Health, 212(3): 239-270.
18. Hayward, K. 2011. Emerging contaminants: the need for a sound-science solution. Water, 21, 13(3): 17-18.
19. Houtman, C. J., van Oostveen, A. M., Brouwer, A., Lamoree, M. H. and Legler, J. 2004. Identification of estrogenic compounds in fish bile using bioassay-directed fractionation. Environmental Science and Technology, 38: 6415-6423.
20. Kasprzyk-Hordern, B., Dinsdale, R. and Guwy, A. 2008. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Research, 42(13): 3498-3518.
21. Kolpin, D. W., Furlong, E. T., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. B. and Buxton, H. T. 2002. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environmental Science and Technology, 36(6): 1202-1211.
22. Kunacheva, C., Tanaka, S., Fujii, S., Boontanon, S. K., Musirat, C. and Wongwattana, T. 2011. Determination of perfluorinated compounds (PFCs) in solid and liquid phase river water samples in Chao Phraya River, Thailand. Water Science and Technology, 64(3): 684-692.
23. Kuster, M., de Alda, M. J., Hernando, M. D., Petrovic, M., Martin-Alonso, J. and Barcelo, D. 2008. Analysis and occurrence of pharmaceuticals, estrogens, progestogens and polar pesticides in sewage treatment plant effluents, river water and drinking water in the Llobregat river basin (Barcelona, Spain). Journal of Hydrology, 358: 112-123.
24. Kwadijk, C. J., Korytar, P. and Koelmans, A. A. 2010. Distribution of perfluorinated compounds in aquatic systems in the Netherlands. Environmental Science and Technology, 44: 3746-3751.
25. Lam, S. H., Hlaing, M. M., Zhang, X., Yan, C., Duan, Z., Zhu, L., Ung, C. Y., Mathavan, S., Ong, C. N. and Gong, Z. 2011. Toxicogenomic and phenotypic analyses of bisphenol-a early-life exposure toxicity in zebrafish. PLoS ONE, 6(12): e28273
26. Lam, S. H., Mathavan, S., Tong, Y., Li, H., Karuturi, R. K., Wu, Y., Vega, V. B., Liu, E. T. and Gong, Z. 2008. Zebrafish whole-adult-organism chemogenomics for large-scale predictive and discovery chemical biology. PLoS Genetics, 4(7): e1000121
27. Li, J. J., Hartono, D., Ong, C. N., Bay, B. H. and Yung, L. Y. 2010. Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials, 31(23): 5996-6003.
28. Loos, R., Locoro, G., Comero, S., Contini, S., Schwesig, D., Werres, F., Balsaa, P., Gans, O., Weiss, S., Blaha, L., Bolchi, M. and Gawlik, B. M. 2010. Pan-European survey on the occurrence of selected polar organic persistent pollutants in ground water. Water Research, 44(14): 4115-4126.
29. Lubick, N. 2009. India's drug problem. Nature, 457: 640-641.
30. McLachlan, M. S., Holmstrom, K. E., Reth, M. and Berger, U. 2007. Riverine discharge of perfluorinated carboxylates from the European continent. Environmental Science and Technology, 41: 7260-7265.
31. Mons, M. N., Hoogenboom, A. C. and Noij, T. H. M. 2003. Pharmaceuticals and Drinking Water Supply in the Netherlands, Kiwa Report BTO 2003.040 Nieuwegein, the Netherlands: Kiwa Water Research.
32. Nguyen, V. T., Reinhard, M. and Karina, G. Y. 2011. Occurrence and source characterization of perfluorochemicals in an urban watershed. Chemosphere, 82(9): 1277-1285.
33. Petrovic, M., Sole, M., de Alda, M. J. L. and Barcelo, D. 2002. Endocrine disruptors in sewage treatment plants, receiving river waters, and sediments: integration of chemical analysis and biological effects on feral carp. Environmental Toxicology and Chemistry, 21: 2146-2156.
34. Rahman, M. F., Yanful, E. K. and Jasim, S. Y. 2009. Endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) in the aquatic environment: implications for the drinking water industry and global environmental health. Journal of Water and Health, 7: 224-243.
35. Reddersen, K., Heberer, T. and Dunnbier, U. 2002. Identification and significance of phenazone drugs and their metabolites in ground- and drinking water. Chemosphere, 49(6): 539-544.
36. Schriks, M., Heringa, M. B., van der Kooi, M. M., de Voogt, P. and van Wezel, A. P. 2009. Toxicological relevance of emerging contaminants for drinking water quality. Water Research, 44: 461-476.
37. Shi, Y., Pan, Y., Wang, J. and Cai, Y. 2011. Distribution of perfluorinated compounds in water, sediment, biota and floating plants in Baiyangdian Lake, China. Journal of Environmental Monitoring, 14(2): 636-642.
38. Skutlarek, D., Exner, M. and Farber, H. 2006. Perfluorinated surfactants in surface and drinking waters. Environmental Science and Pollution Research International, 13: 299-307.
39. Stanford, B. D., Trenholm, R. A., Holady, J. C., Vanderford, B. J. and Snyder, S. A. 2010. Estrogenic activity of US drinking waters: a relative exposure comparison. Journal of the American Water Works Association, 110(11): 55-65.
40. Sukardi, H., Chng, H. T., Chan, E. C., Gong, Z. and Lam, S. H. 2011. Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models. Expert Opinion on Drug Metabolism & Toxicology, 7: 579-589.
41. Sun, H., Li, F., Zhang, T., Zhang, X., He, N., Song, Q., Zhao, L., Sun, L. and Sun, T. 2011. Perfluorinated compounds in surface waters and WWTPs in Shenyang, China: mass flows and source analysis. Water Research, 45(15): 4483-4490.
42. Ternes, T. 2001. "Pharmaceuticals and metabolites as contaminants of the aquatic environment". In Pharmaceuticals and Care Products in the Environment, Edited by: Daughton, C. G. and Jones-Lepp, T. L. 39-55. Washington, DC: American Chemical Society.
43. Thompson, J., Eaglesham, G. and Mueller, J. 2011. Concentrations of PFOS, PFOA and other perfluorinated alkyl acids in Australian drinking water. Chemosphere, 83(10): 1320-1325.
44. Tong, Y., Shan, T., Poh, Y. K., Yan, T., Wang, H., Lam, S. H. and Gong, Z. 2004. Molecular cloning of zebrafish and medaka vitellogenin genes and comparison of their expression in response to 17beta-estradiol. Gene, 328: 25-36.
45. USGS. 2011. Toxic Substances Hydrology Program: Emerging Contaminants in the Environment, US Geological Survey. Available at: http://toxics.usgs.gov/regional/emc/ (accessed 7 March 2012)
46. Watts and Crane Associates. 2007. Desk Based Review of Current Knowledge on Pharmaceuticals in Drinking Water and Estimation of Potential Levels: Final Report to DWI (Defra Project Code: CSA 7184/WT02046/DWI70/2/213), Faringdon, UK: Watts and Crane Associates.
47. Watts, M. M., Pascoe, D. and Carroll, K. 2002. Population responses of the freshwater amphipod Gammarus pulex (L.) to an environmental estrogen, 17α-ethinylestradiol. Environmental Toxicology and Chemistry, 21: 445-450.
48. Wenzel, A., Müller, J. and Ternes, T. 2003. Study on endocrine disrupters in drinking water: Final Report ENV.D.1/ETU/2000/0083, Smallenberg: European Commission.
49. WHO. 2002. Global Assessment of the State-of-the-Science of Endocrine Disruptors, WHO/PCS/EDC/02.2, Geneva: World Health Organization.
50. WHO. 2011a. Pharmaceuticals in Drinking Water, Geneva: World Health Organization.
51. WHO. 2011b. Guidelines for Drinking-Water Quality, 4th ed., Geneva: World Health Organization.
52. Zhang, T., Sun, H., Lin, Y., Wang, L., Zhang, X., Liu, Y., Geng, X., Zhao, L., Li, F. and Kannan, K. 2011. Perfluorinated compounds in human blood, water, edible freshwater fish, and seafood in China: daily intake and regional differences in human exposures. Journal of Agriculture and Food Chemistry, 59(20): 11168-11176.